By Iain Gilbert
Date: Thursday 06 Feb 2025
(Sharecast News) - Shares in pharmaceutical giant Bristol Myers Squibb headed south in early trading as its solid Q4 revenue performance was offset by FY25 guidance that fell short of Wall Street expectations.
By Benjamin Chiou
Date: Thursday 25 Apr 2024
(Sharecast News) - US drugmaker Bristol Myers Squibb on Thursday announced plans to cut its workforce by 6% as part of a $1.5bn cost-savings programme, as it reported better-than-expected results for the first quarter.
By Benjamin Chiou
Date: Friday 22 Dec 2023
(Sharecast News) - Biopharmaceuticals giant Bristol Myers Squibb has announced it is spending $14bn to purchase Karuna Therapeutics, which develops treatments for people living with psychiatric and neurological conditions.
GlaxoSmithKline denies interest in Aurinia | 01-Nov-2021 | ShareCast |
Bristol Myers acquires Celgene in $74bn pharma d... | 03-Jan-2019 | ShareCast |
Jefferies cuts AstraZeneca target price | 01-Aug-2017 | ShareCast |
Analysts pick winners as pharma sector bounces b... | 09-Nov-2016 | ShareCast |
Currency | US Dollars |
Share Price | $ 59.55 |
Change Today | $ -1.44 |
% Change | -2.36 % |
52 Week High | $63.11 |
52 Week Low | $39.66 |
Volume | 9,623,818 |
Shares Issued | 2,006.00m |
Market Cap | $119,457m |
RiskGrade | 106 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 17 |
Sell | 2 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
15:59 | 100 @ $59.51 |
15:59 | 149 @ $59.52 |
15:59 | 100 @ $59.52 |
15:59 | 100 @ $59.52 |
15:59 | 100 @ $59.52 |
You are here: research